Parkinson's Disease: World Drug Market 2011-2021Visiongain
September 26, 2011
142 Pages - SKU: VSG6653333
5.7 Rest of the World: Market Forecast 2011-2021
The revenues of the ‘Rest of the World’ market are predominantly derived from the developed markets of the Anglosphere, particularly New Zealand, Australia, and Canada, although the other two BRIC (Brazil, Russia, India and China) countries are also showing strong growth.
Brainstorm Cell Therapeutics
Buck Institute for Research on Aging
Dresden University of Technology
Kyowa Hakko Kirin
Merck & Co.
Mitsubishi Gas Chemical
National Institute of Neurological Disorders and Stroke [NINDS]
Pacific Rainbow International
ShenZhou Biology & Technology
Teva Pharmaceutical Industries
University of Bristol Institute of Clinical Neuroscience
University of Kentucky
University of Nebraska
University of Rochester
Weill Medical College, Cornell University
Xiamen Kingdomway Group
Zhejiang Medicine Company
More Parkinson's Disease reports by Visiongain
Neuroprotective Products: World Market Prospects 2012-2022 by VisiongainSee all reports like this >>
What are the commercial prospects for neuroprotective treatments? Visiongain's new report shows you potential revenues and trends to 2022, discussing data, opportunities and outlooks. ...
More Global Parkinson's Disease reports
Parkinson's Disease Global Clinical Trials Review, H2, 2012 by GlobalData
Parkinson's Disease Global Clinical Trials Review, H2, 2012SummaryGlobalData's clinical trial report, “Parkinson’s Disease Global Clinical Trials Review, H2, 2012\ provides data on the Parkinson’s Disease ...
Vaccines 2012-16 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments by Kalorama Information
This report examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for ...
Global Markets for Treatments of Dementia and Movement Disorders - Focus on Movement Disorders by BCC Research
The global market for treatments for syndromes of dementia and movement disorders was valued at $10.5 billion in 2011 and should reach $11.1 billion in ...
Analyzing the Global CNS Market by Aruvian's R'searchSee all reports like this >>
The CNS market at a global scale is one of the largest and fastest growing markets in the pharmaceutical industry. Reimbursement terms remain favorable within ...
We can help you find what you need. Call us or write us:
Need help in your search?
Parkinson's Disease Reports
- Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson’s disease treatment will boost market despite patent cliff
- Parkinson's Disease – Pipeline Review, H1 2013
- Parkinson's Disease Global Clinical Trials Review, H2, 2012
- Vaccines 2012-16 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments
- Market and Product Forecasts: Top 10 Neurology Brands 2011–21